Candidate live, attenuated Salmonella enterica serotype typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines

Infection and Immunity

Volumn 75, Issue 4, 2007, Pages 1835-1842

  El Ghany, Moataz Abd ^a   Jansen, Angela ^a   Clare, Simon ^a   Hall, Lindsay ^a   Pickard, Derek ^a   Kingsley, Robert A ^a   Dougan, Gordon ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FECES; FEMALE; GENE MUTATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MISL GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RATB GENE; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SHDA GENE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; FECES; FEMALE; GENES, BACTERIAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-2; LYMPHOCYTES; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; SPLEEN; TETANUS TOXIN; VACCINES, ATTENUATED;

EID: 34147142418     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01655-06     Document Type: Article

References (24)

1. Abreu, P. A., P. A. Miyasato, M. M. Vilar, W. O. Dias, P. L. Ho, M. Tendler, and A. L. Nascimento. 2004. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice. Infect. Immun. 72:5931-5937.
2. Anderson, R., X. M. Gao, A. Papakonstantinopoulou, M. Roberts, and G. Dougan. 1996. Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin. Infect. Immun. 64:3368-3173.
3. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
4. Bochner, B. R. 1984. Curing bacterial cells of lysogenic viruses by using UCB indicator plates. BioTechniques 2:234-240.
5. Cardenas, L., U. Dasgupta, and J. D. Clements. 1994. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 12:833-840.
6. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
7. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
8. Dorsey, C. W., M. C. Laarakker, A. D. Humphries, E. H. Weening, and A. J. Baumler. 2005. Salmonella enterica serotype Typhimurium MisL is an intestinal colonization factor that binds fibronectin. Mol. Microbiol. 57:196-211.
9. Hindle, Z., S. N. Chatfield, J. Phillimore, M. Bentley, J. Johnson, C. A. Cosgrove, M. Ghaem-Maghami, A. Sexton, M. Khan, F. R. Brennan, P. Everest, T. Wu, D. Pickard, D. W. Holden, G. Dougan, G. E. Griffin, D. House, J. D. Santangelo, S. A. Khan, J. E. Shea, R. G. Feldman, and D. J. Lewis. 2002. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect. Immun. 70:3457-3467.
10. Hohmann, E. L., C. A. Oletta, and S. I. Miller. 1996. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14:19-24.
11. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live oral vaccines. Nature 291:238-239.
12. Kingsley, R. A., A. D. Humphries, E. H. Weening, M. R. De Zoete, S. Winter, A. Papaconstantinopoulou, G. Dougan, and A. J. Baumler. 2003. Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype Typhimurium: identification of intestinal colonization and persistence determinants. Infect. Immun. 71:629-640.
13. Kingsley, R. A., A. M. Keestra, M. R. de Zoete, and A. J. Baumler. 2004. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding. Mol. Microbiol. 52:345-355.
14. Kingsley, R. A., K. van Amsterdam, N. Kramer, and A. J. Baumler. 2000. The shdA gene is restricted to serotypes of Salmonella enterica subspecies I and contributes to efficient and prolonged fecal shedding. Infect. Immun. 68:2720-2727.
15. Kotton, C. N., and E. L. Hohmann. 2004. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect. Immun. 72:5535-5547.
16. Kotton, C. N., A. J. Lankowski, N. Scott, D. Sisul, L. M. Chen, K. Raschke, G. Borders, M. Boaz, A. Spentzou, J. E. Galan, and E. L. Hohmann. 2006. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine 24:6216-6224.
17. Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Baqar, M. F. Edwards, et al. 1987. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Investig. 79:888-902.
18. Medaglini, D., A. Ciabattini, M. R. Spinosa, T. Maggi, H. Marcotte, M. R. Oggioni, and G. Pozzi. 2001. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19:1931-1939.
19. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. Baker, D. Basbam, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larsen, S. Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848-852.
20. Parry, C. M., T. T. Hien, G. Dougan, N. J. White, and J. J. Farrar. 2002. Typhoid fever. N. Engl. J. Med. 347:1770-1782.
21. Tacket, C. O., G. Losonsky, D. N. Taylor, L. S. Baron, D. Kopecko, S. Cryz, and M. M. Levine. 1991. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies. J. Infect. Dis. 163:901-904.
22. Townsend, S. M., N. E. Kramer, R. Edwards, S. Baker, N. Hamlin, M. Simmonds, K. Stevens, S. Maloy, J. Parkhill, G. Dougan, and A. J. Bäumler. 2001. Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect. Immun. 69:2894-2901.
23. Tregoning, J. S., S. Clare, F. Bowe, L. Edwards, N. Fairweather, O. Qazi, P. J. Nixon, P. Maliga, G. Dougan, and T. Hussell. 2005. Protection against tetanus toxin using a plant-based vaccine. Eur. J. Immunol. 35:1320-1326.
24. Weening, E. H., J. D. Barker, M. C. Laarakker, A. D. Humphries, R. M. Tsolis, and A. J. Baumler. 2005. The Salmonella enterica serotype Typhimurium lpf, bcf, stb, stc, std, and sth fimbrial operons are required for intestinal persistence in mice. Infect. Immun. 73:3358-3366.